Atkinson E A, Barry M, Darmon A J, Shostak I, Turner P C, Moyer R W, Bleackley R C
Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada.
J Biol Chem. 1998 Aug 14;273(33):21261-6. doi: 10.1074/jbc.273.33.21261.
Cytototoxic T lymphocyte-induced apoptosis can occur either through the directed exocytosis of granzyme B and perforin or via ligation of Fas. Both pathways involve the activation of a family of cysteine proteinases, the caspases, that cleave substrates at aspartic acid and are themselves activated by cleavage at internal aspartate residues. Fas recruits caspase 8, which initiates the death program through the subsequent activation of caspase 3. Granzyme B can process both caspase 8 and 3 in vitro, suggesting that both Fas and granzyme B access the apoptotic program in the same way. Here we demonstrate that although the two mechanisms are similar, the events that lead to activation of caspase 3 can be distinguished in vivo on the basis of their sensitivities to both pharmacological and virus-encoded caspase inhibitors. In cytotoxic T lymphocytes-mediated death the initial cleavage event on caspase 3 is insensitive to benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone (zVAD-fmk) inhibition in both mouse and human systems. During Fas-mediated death, however, activation of caspase 3 is completely inhibited to zVAD-fmk. In addition, the viral serpin SPI-2, a homologue of cytokine response modifier A (crmA), is an effective inhibitor of the Fas but not the granzyme pathway. Our results demonstrate that whereas Fas-mediated activation of caspase 3 requires an upstream caspase activity that is zVAD-fmk-sensitive, the initial cleavage of caspase 3 during granule-mediated cell death is insensitive to zVAD-fmk, suggesting that caspase 3 is cleaved directly by granzyme B in vivo.
细胞毒性T淋巴细胞诱导的凋亡可通过颗粒酶B和穿孔素的定向胞吐作用或通过Fas的连接发生。这两条途径都涉及半胱氨酸蛋白酶家族(即胱天蛋白酶)的激活,这些酶在天冬氨酸处切割底物,并且自身通过内部天冬氨酸残基的切割而被激活。Fas招募胱天蛋白酶8,其通过随后激活胱天蛋白酶3启动死亡程序。颗粒酶B在体外可加工胱天蛋白酶8和3,这表明Fas和颗粒酶B以相同方式进入凋亡程序。在这里,我们证明尽管这两种机制相似,但基于它们对药理学和病毒编码的胱天蛋白酶抑制剂的敏感性,在体内可以区分导致胱天蛋白酶3激活的事件。在细胞毒性T淋巴细胞介导的死亡中,在小鼠和人类系统中,胱天蛋白酶3上的初始切割事件对苄氧羰基-Val-Ala-Asp氟甲基酮(zVAD-fmk)抑制不敏感。然而,在Fas介导的死亡过程中,胱天蛋白酶3的激活被zVAD-fmk完全抑制。此外,病毒丝氨酸蛋白酶抑制剂SPI-2是细胞因子反应调节因子A(crmA)的同源物,是Fas途径而非颗粒酶途径的有效抑制剂。我们的结果表明,虽然Fas介导的胱天蛋白酶3激活需要上游对zVAD-fmk敏感的胱天蛋白酶活性,但在颗粒介导的细胞死亡过程中,胱天蛋白酶3的初始切割对zVAD-fmk不敏感,这表明胱天蛋白酶3在体内被颗粒酶B直接切割。